Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2413032060
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cervantes, L. F.
Right arrow Articles by Medina, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cervantes, L. F.
Right arrow Articles by Medina, L. S.
(Radiology 2006;241:936-938.)
© RSNA, 2006


Diagnosis Please

Case 102: Pituitary Aplasia1

Luisa F. Cervantes, MD, Nolan R. Altman, MD and L. Santiago Medina, MD

1 From the Department of Radiology, Miami Children's Hospital, 3100 SW 62nd Ave, Miami, FL 33155. Received December 15, 2003; revision requested February 19, 2004; revision received May 25; accepted June 15; final version accepted October 20.

Correspondence: Address correspondence to L.F.C. (e-mail: lulu_cervantes{at}hotmail.com).


    HISTORY
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
A full-term boy was born to a 33-year-old woman (gravida 3, para 2) after an uneventful pregnancy. The baby was delivered by means of cesarean section when labor failed to progress. At birth, the baby weighed 3685 g, was 50.8 cm long, and had an Apgar score of 8 at 1 minute and of 10 at 5 minutes. The baby's blood glucose level at 2 hours of age was 7 mg/dL (0.39 mmol/L). At that time, he was transferred to the regular nursery, and dextrose infusion was started. Twenty hours later, he was found to be lethargic and hypothermic. His blood glucose level was immediately measured and found to be 2 mg/dL (0.11 mmol/L). A physical examination was performed, and a micropenis and bilaterally descended testicles were noted. The patient was transferred to a tertiary pediatric medical center, and magnetic resonance (MR) imaging of the brain was performed.


    IMAGING FINDINGS
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
Sagittal and coronal MR images obtained through the sella (Figure, parts a and b) showed the anterior pituitary gland was absent. The posterior pituitary gland, which is indicated by an area of high signal intensity, was not visible in either the sella or the hypothalamic region. The sella turcica was flattened and shallow. The optic chiasm was normal in size and morphology. The transverse MR image obtained through the suprasellar region (Figure, part c) showed that there was no pituitary stalk.


Figure 1
View larger version (154K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure a: (a) Sagittal and (b) coronal T1-weighted MR images (repetition time msec/echo time msec, 500/12; section thickness, 3 mm) obtained through the sella show absence of the anterior pituitary gland. The absence of a high-signal-intensity area indicates that the posterior pituitary gland is not seen in either the sella or the hypothalamic region. The sella turcica (arrow) is flattened and shallow. The optic chiasm (arrowhead) is normal in size and morphology. (c) Transverse T1-weighted MR image (525/10; section thickness, 3 mm) obtained through the suprasellar region shows that there is no pituitary stalk, but there are normal optic nerves (arrowheads).

 

Figure 1
View larger version (144K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure b: (a) Sagittal and (b) coronal T1-weighted MR images (repetition time msec/echo time msec, 500/12; section thickness, 3 mm) obtained through the sella show absence of the anterior pituitary gland. The absence of a high-signal-intensity area indicates that the posterior pituitary gland is not seen in either the sella or the hypothalamic region. The sella turcica (arrow) is flattened and shallow. The optic chiasm (arrowhead) is normal in size and morphology. (c) Transverse T1-weighted MR image (525/10; section thickness, 3 mm) obtained through the suprasellar region shows that there is no pituitary stalk, but there are normal optic nerves (arrowheads).

 

Figure 1
View larger version (145K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure c: (a) Sagittal and (b) coronal T1-weighted MR images (repetition time msec/echo time msec, 500/12; section thickness, 3 mm) obtained through the sella show absence of the anterior pituitary gland. The absence of a high-signal-intensity area indicates that the posterior pituitary gland is not seen in either the sella or the hypothalamic region. The sella turcica (arrow) is flattened and shallow. The optic chiasm (arrowhead) is normal in size and morphology. (c) Transverse T1-weighted MR image (525/10; section thickness, 3 mm) obtained through the suprasellar region shows that there is no pituitary stalk, but there are normal optic nerves (arrowheads).

 

    DISCUSSION
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
In a newborn, persistent neonatal hypoglycemia has multiple metabolic and endocrinologic etiologies. Metabolic etiologies are found in most instances of persistent neonatal hypoglycemia (1). However, the clinical finding of micropenis in our patient suggested hypopituitarism; thus, imaging studies were obtained and revealed aplasia of the pituitary gland. Congenital pituitary gland absence (aplasia) is a rare anomaly that involves absence of both the anterior and the posterior pituitary lobes and, in many cases, the pituitary stalk (2).

An endocrinologic cause of micropenis reflects a deficiency of testosterone, dehydrotestosterone, or growth hormone; these hormones are needed for normal penile growth to occur beyond 14 weeks of gestation. The major causes of micropenis include hypopituitarism (in 30% of cases), primary hypogonadism (in 25% of cases), and idiopathic undiagnosed causes (in 45% of cases) (1). The association of micropenis with early neonatal hypoglycemia should immediately raise the possibility of congenital hypopituitarism.

In patients with neonatal panhypopituitarism, severe symptoms of hypoglycemia may appear during the 1st hours of life. Symptoms include seizures, apnea, and cardiovascular collapse and arrest. The infants are of normal length and weight and are born at term or postterm. A physical examination may be unrevealing; however, some male infants have a microphallus, a poorly developed scrotum, and/or small undescended testes. Facial abnormalities—including cleft lip and palate, poorly developed nasal septum, and hypotelorism or hypertelorism—have been reported. Abnormalities of antidiuretic hormone secretion have also been described. Although the size of infants is normal at birth, growth retardation and delayed bone age may be found at 6–8 weeks of age (1).

Neonatal hypoglycemia associated with poorly functioning anterior pituitary gland may represent a series of separate syndromes with no structural brain anomalies or with defects such as craniofacial defects, absence of septum pellucidum, septo-optic dysplasia, arrhinencephaly, holoprosencephaly, and anencephaly (1). It is well known that anencephalic newborns lack an identifiable pituitary gland and have hypoplasia of the adrenal glands (3,4). Congenital absence of the pituitary gland without a major brain anomaly is a rare disorder. Most infants with this disorder die in early infancy, and the anomaly is diagnosed at autopsy.

The exact mechanism of hypoglycemia in panhypopituitarism remains unclear. Hypoglycemia is thought to result from a cortisol deficiency. Absence or severe atrophy of the fetal zone of the adrenal cortex is a consistent finding in patients with pituitary aplasia (3). This is thought to indicate an adrenocorticotropic hormone deficiency; histologic samples obtained in patients with this disorder have an appearance that is distinctly different from that of patients with primary adrenal hypoplasia, in whom fetal zone cells are preserved (3). Growth hormone deficiency may also contribute to the low blood glucose level. Hypopituitarism as a cause of hypoglycemia is self-limited, and older children may not need continued growth hormone therapy to maintain normal glucose concentration. Cortisol replacement for glucose control, however, may need to be continued even if growth hormone therapy is no longer essential. The normal size of the infant at birth has been explained by the presence of maternal growth hormone.

The characteristic imaging finding of pituitary aplasia is absence of an identifiable pituitary gland. In addition, the sella is small and flat, and it is sometimes covered by a layer of dura. The differential diagnosis includes severe hypoplasia of the pituitary gland. However, this was not the most likely diagnosis in this case, as there was no pituitary stalk or posterior pituitary gland. In addition, the sella was flattened, and this indicated that no pituitary tissue was formed. The differential diagnosis may also include empty sella, in which the pituitary gland is severely flattened. In patients with empty sella, the superior portion of the sella turcica appears empty but is actually filled with cerebrospinal fluid (5). The empty sella is presumed to result from a deficient diaphragma sellae with resultant extension of the cerebrospinal fluid into the sella, exposing it to cerebrospinal fluid pulsation and eventually resulting in enlargement of the sella turcica. Empty sella is an uncommon finding that is encountered in children (6). Most frequently, the empty sella is an incidental finding of little or no clinical importance. Patients with empty sella do not have related endocrine abnormalities because the pituitary function is normal. In patients with empty sella, the sella is normal or enlarged.


    FOOTNOTES
 

Part one of this case appeared 4 months previously and may contain larger images.

 


    References
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 

  1. Kalhan SC, Parimi PS. Metabolic and endocrine disorders. In: Fanaroff AA, Martin RJ, eds. Neonatal-perinatal medicine: diseases of the fetus and infants. 7th ed. St Louis, Mo: Mosby, 2002; 1355–1367.
  2. Barkovich AJ. Congenital malformations of the brain and skull. In: Barkovich AJ. Pediatric neuroimaging. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2000; 351–352.
  3. Sadeghi-Nejad A, Senior B. A familial syndrome of isolated "aplasia" of the anterior pituitary: diagnostic studies and treatment in the neonatal period. J Pediatr 1974;84:79–84.[CrossRef][Medline]
  4. Blizzard RM, Alberts M, Moines D. Hypopituitarism, hypoadrenalism and hypogonadism in the newborn infant. J Pediatr 1956;48:782–792.[CrossRef][Medline]
  5. Kucharczyk W, Montanera WJ, Becker LE. The sella turcica and the parasellar region. In: Atlas S, ed. Magnetic resonance imaging of the brain and spine. 2nd ed. Philadelphia, Pa: Lippincott-Raven, 1996; 880–883.
  6. Zucchini S, Ambrosetto P, Carla G, Tani G, Franzoni E, Cacciari E. Primary empty sella: differences and similarities between children and adults. Acta Paediatr 1995;84:1382–1385.[Medline]
Congratulations to the 77 individuals and five resident groups that submitted the most likely diagnosis (pituitary aplasia) for Diagnosis Please, Case 102. The names and locations of the individuals and resident groups, as submitted, are as follows:

Individual responses

Gholamali Afshang, MD, Tinley Park, Ill
Dr Erhan Akpinar, Ankara, Turkey
Canan Altay, MD, Balcova, Izmir, Turkey
Ken Baliga, Rockford, Ill
Michael Lewis Black, MD, Irvine, Calif
Eric L. Bressler, MD, Minnetonka, Minn
Daniel F. Broderick, MD, Jacksonville, Fla
Douglas C. Brown, MD, Virginia Beach, Va
Carlos Capiel, Jr, MD, Mar del Plata, Buenos Aires, Argentina
Kam Wai Chan, Hong Kong, Hong Kong
Natesan Chidambaranathan, MD, Chennai, India
Royce A. Chrys, MD, Oakland, Calif
Haris Chrysikopoulos, MD, Kerkyra, Greece
Yves-Sebastien Cordoliani, MD, Paris, France
Marc G. de Baets, MD, Lugano, Switzerland
J. F. K. de Villiers, Gisborne, New Zealand
Jon James De Witte, Bishop, Ga
Seena Dehkharghani, MD, Phoenix, Ariz
Seyed Emamian, MD, PhD, Rockville, Md
Shella Farooki, MD, Dublin, Ohio
Dr James FitzGerald, Milsons Point, New South Wales, Australia
Akira Fujikawa, Tokyo, Japan
Karthik Ganesan, Mumbai, India
Douglas Joseph Gardner, MD, Windsor, Ontario, Canada
Moshe Goldfeld, Nahariya, Israel
Mark G. Goldshein, MD, Andover, Mass
Dan G. Gridley, MD, Phoenix, Ariz
Ferris M. Hall, MD, Boston, Mass
Alberto Iaia, MD, Wilmington, Del
Mehmet Kocak, MD, Milwaukee, Wis
Kaori Koga, Oakleigh, Australia
Kavitha Kothur, Hyderabad, Andhra Pradesh, India
Mario Laguna, West Allis, Wis
Dr Martin Lecompte, Ottawa, Ontario, Canada
John Lai Yin Leung, MBBS, Chai Wan, Hong Kong
Marina Lucchesi, Junin, Buenos Aires, Argentina
Naganathan B. S. Mani, MD, Nassau, Bahamas
Michael B. Martin, MD, Austin, Tex
Fernando Mas-Estelles, Valencia, Spain
Waldir Heringer Maymone, MD, Rio de Janeiro, Brazil
Nikolaos Michailidis, MD, Thessaloniki, Greece
Manabu Minami, MD, Tsukuba, Ibaraki, Japan
Jose Mondello, MD, Buenos Aires, Argentina
Albert Nizzero, MD, Sudbury, Ontario, Canada
Laura Oleaga, MD, Bilbao, Spain
Sanford M. Ornstein, MD, Phoenix, Ariz
Ann Burleson Owen, MD, Murfreesboro, Tenn
Rajeev Padmanabhan, MBBS, Newcastle upon Tyne, United Kingdom
Harish Panicker, MD, Hermitage, Pa
Narendrakumar P. Patel, MD, Newburgh, NY
Prakash N. Patel, MD, New City, NY
Yeliz Pekcevik, Izmir, Turkey
Henry F. W. Pribram, MD, Laguna Beach, Calif
Prashant Raghavan, MD, Charlottesville, Va
Marcio Bustamante Sa Rodrigues, MD, Rio de Janeiro, Brazil
Tsutomu Sakamoto, MD, Tokyo, Japan
Hatice Tuba Sanal, MD, Ankara, Turkey
Steven Schepers, MD, Herent, Belgium
Anthony J. Scuderi, Johnstown, Pa
Matt Shapiro, MD, Charlottesville, Va
Grady Shue, Jr, MD, Hickory, NC
Ken Simmons, Sydney, Australia
David F. Sobel, MD, La Jolla, Calif
James D. Sprinkle, Jr, MD, Spotsylvania, Va
Vinod Sukumaran II, MD, Trivandrum, India
Venkateswar Rao Surabhi, MBBS, Herndon, Va
Douglas L. Teich, MD, Brookline, Mass
Kazuma Terauchi, Fujieda, Shizuoka, Japan
Dr Özgür Tosun, Bilkent, Ankara, Turkey
Shigeaki Umeoka, MD, Wakayama, Japan
Eleni Vafeiadou, Thessaloniki, Greece
Joan C. Vilanova, MD, Girona, Spain
Christopher P. Vittore, MD, Rockford, Ill
Nikolaos Vougiouklis, Kalamaria, Greece
Robert Charles Weissmann, MD, Birmingham, Ala
Steven Thomas Welch, MD, Kansas City, Mo
Edward Williams, Isle of Man, United Kingdom

Resident group response

Hospital Italiano Córdoba Radiology Residents, Córdoba, Argentina
Kyoto City Hospital Radiology Residents, Kyoto, Japan
Maine Medical Center Radiology Residents, Portland, Me
Trakya University School of Medicine Radiology Residents, Edirne, Turkey
University of Pennsylvania Radiology Residents, Philadelphia, Pa





This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cervantes, L. F.
Right arrow Articles by Medina, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cervantes, L. F.
Right arrow Articles by Medina, L. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE